| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.003 | 1 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |